Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

fluoxymesterone

A halogenated derivative of 17-alpha-methyltestosterone. Similar to testosterone, fluoxymesterone binds to and activates specific nuclear receptors, resulting in an increase in protein anabolism, a decrease in amino acid catabolism, and retention of nitrogen, potassium, and phosphorus. This agent also may competitively inhibit prolactin receptors and estrogen receptors, thereby inhibiting the growth of hormone-dependent tumor lines. Fluoxymesterone is approximately five times more potent than methyltestosterone.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Androfluorene
Androsterolo
US brand name:Android-F
Halodrin
Halotestin
Ora-Testryl
Ultandren
Foreign brand name:Oratestin
Stenox
Testoral
Abbreviation:FXM
Chemical structure:(11Beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one
11Beta,17beta-dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one
9Alpha-fluoro-11beta-hydroxy-17alpha-methyltestosterone
IND number:4573
NSC code:12165
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search